Lv11
85 积分 2021-11-06 加入
Immune checkpoint inhibitor resistance in hepatocellular carcinoma
6小时前
待确认
Mechanisms of drug resistance in HCC
6小时前
已完结
PD-L1 expression according to the EGFR status in primary lung adenocarcinoma
6天前
已完结
Interactions between EGFR and PD-1/PD-L1 pathway: Implications for treatment of NSCLC
6天前
已完结
EGFR-TKIs resistance via EGFR-independent signaling pathways
6天前
已完结
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
6天前
已完结
Targeting DDOST improves the efficacy of lenvatinib and immunotherapy in hepatocellular carcinoma
6天前
已完结
EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
6天前
已完结
EGFR signaling pathway as therapeutic target in human cancers
6天前
已完结
Overcoming Resistance to Tumor-Targeted and Immune-Targeted Therapies
6天前
已完结
皖公网安备34019202002308
